Načítá se...
rhTPO联合大剂量地塞米松治疗儿童难治性免疫性血小板减少症的临床分析
OBJECTIVE: To explore the effcacy and safety of recombinant human thrombopoietin (rhTPO) combined with high-dose dexamethasone (DXM) in the treatment of children with refractory immune thrombocytopenic purpura (ITP). METHODS: Fifty-eight ITP children who had failed frst-line therapy were randomly di...
Uloženo v:
| Vydáno v: | Zhongguo Dang Dai Er Ke Za Zhi |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
中国当代儿科杂志编辑部
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7389201/ https://ncbi.nlm.nih.gov/pubmed/30022753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7499/j.issn.1008-8830.2018.07.004 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|